Knocking down disease: a progress report on siRNA therapeutics
Crossref DOI link: https://doi.org/10.1038/nrg3978
Published Online: 2015-08-18
Published Print: 2015-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wittrup, Anders
Lieberman, Judy
Text and Data Mining valid from 2015-08-18
Article History
First Online: 18 August 2015
Competing interests
: J.L. is on the Scientific Advisory Board of Alnylam Pharmaceuticals. A.W. declares no competing interests.